I'm looking for a job. I exported this list from FewerJobs.com - a curated job board.

Please:
1. Rank these jobs by fit for me, given my resume / skills.
2. Highlight the top 5 with a one-sentence rationale each.
3. Flag any concerns, including benefit values without source-backed evidence.
4. Suggest one or two filter changes I could make on FewerJobs to find more good matches.

Filters I applied:
- q: Olema Pharmaceuticals
- quality_floor: all
- match_401k_strict: true
- parental_strict: true
- non_birth_strict: true
- pto_strict: true
- include_older: false
- apply_url_verified: false
- page: 1
- per_page: 100
- sort: relevance

Jobs (100 total):

---
TITLE: Senior Clinical Trial Associate
EMPLOYER: Olema Pharmaceuticals
LOCATION: San Francisco, California (unspecified)
SALARY: $110K-$120K
POSTED: 2026-06-04
APPLY_URL: https://job-boards.greenhouse.io/olema/jobs/5842651004
EXCERPT: Senior Clinical Trial Associate San Francisco, California Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breast cancer with blockbuster potential as a monotherapy and in combination in ER+/HER2- metastatic breast cancer. Our follow-on product candidate, OP-3136, is a potent KAT6 inhibitor with best-in-class potential. Our scientific breakthroughs are accelerated through the ways in which we fearlessly support, motivate, and challenge one another. At Olema, we know that when we put people first, our work becomes second to none. If you're ready to join us at the edge of something unstoppable, let's make a profound impact together for our patients, for your career, for what's beyond . You can view our latest corporate deck and other presentations here . About the Role >>> Senior Clinical Trial Associate As the Senior Clinical Trial Associate reporting to the Senior Manager, Clinical Trial Leader, you will provide comprehensive administrative and operational support to clinical team members across all study activities, including both in-house and outsourced trials. This role supports cross-functional study execution through coordination with internal teams, external vendors, and site staff, and may include contributing to study documentation such as informed consent forms (ICFs) and central IRB submissions, supporting site payments and other study-related operational activities, as well as liaising with and following up with investigator sites. Responsibilities include assisting with study start-up, maintenance, and closeout activities; managing study documentation and
---
TITLE: Lead Senior Medical Writer
EMPLOYER: Olema Pharmaceuticals
LOCATION: Boston, Massachusetts (unspecified)
SALARY: $160K-$175K
POSTED: 2026-06-04
APPLY_URL: https://job-boards.greenhouse.io/olema/jobs/5848134004
EXCERPT: Lead Senior Medical Writer Boston, Massachusetts Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breast cancer with blockbuster potential as a monotherapy and in combination in ER+/HER2- metastatic breast cancer. Our follow-on product candidate, OP-3136, is a potent KAT6 inhibitor with best-in-class potential. Our scientific breakthroughs are accelerated through the ways in which we fearlessly support, motivate, and challenge one another. At Olema, we know that when we put people first, our work becomes second to none. If you're ready to join us at the edge of something unstoppable, let's make a profound impact together for our patients, for your career, for what's beyond . You can view our latest corporate deck and other presentations here . About the Role >>> Lead Senior Medical Writer As the Lead Senior Medical Writer, reporting to the Director of Medical Writing, you will lead the development, and delivery of high-quality scientific and regulatory documents supporting Olema's oncology portfolio. This role requires strong cross-functional leadership, partnering closely with Clinical Science, Clinical Development, Regulatory Affairs, Biometrics, and other stakeholders to translate complex clinical and preclinical data into clear, accurate, and compelling content for regulatory submissions, medical communications, and scientific publications. In addition, you will drive consistency, quality, and timelines across deliverables, contributing to the overall medical writing strategy and supporting key regulatory and clinical milestones. This role is based out of our Boston,
---
TITLE: Senior Director, Marketing
EMPLOYER: Olema Pharmaceuticals
LOCATION: San Francisco, California (unspecified)
SALARY: $250K-$285K
POSTED: 2026-06-04
APPLY_URL: https://job-boards.greenhouse.io/olema/jobs/5480105004
EXCERPT: Senior Director, Marketing San Francisco, California Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breast cancer with blockbuster potential as a monotherapy and in combination in ER+/HER2- metastatic breast cancer. Our follow-on product candidate, OP-3136, is a potent KAT6 inhibitor with best-in-class potential. Our scientific breakthroughs are accelerated through the ways in which we fearlessly support, motivate, and challenge one another. At Olema, we know that when we put people first, our work becomes second to none. If you're ready to join us at the edge of something unstoppable, let's make a profound impact together for our patients, for your career, for what's beyond . You can view our latest corporate deck and other presentations here . About the Role >>> Senior Director, Marketing As the Senior Director, Marketing you will design and execute the Commercial roadmap that enables the successful potential U.S. launch of palazestrant, Olema's lead program currently in Phase 3 for ER+ HER2- metastatic breast cancer. The ideal candidate will have experience in the commercialization of oral oncology therapies in breast cancer and a track record of leading successful oncology drug launches in the US. This role is based out of our San Francisco office and will require travel as needed. Your work will primarily encompass: Building the strategic marketing plan and leading launch readiness initiatives (branding, positioning, messaging platform, story flow and creative imagery)
---
TITLE: Associate Director, Analytical Development
EMPLOYER: Olema Pharmaceuticals
LOCATION: Boston, Massachusetts (unspecified)
SALARY: $190K-$205K
POSTED: 2026-06-04
APPLY_URL: https://job-boards.greenhouse.io/olema/jobs/5850028004
EXCERPT: Associate Director, Analytical Development Boston, Massachusetts Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breast cancer with blockbuster potential as a monotherapy and in combination in ER+/HER2- metastatic breast cancer. Our follow-on product candidate, OP-3136, is a potent KAT6 inhibitor with best-in-class potential. Our scientific breakthroughs are accelerated through the ways in which we fearlessly support, motivate, and challenge one another. At Olema, we know that when we put people first, our work becomes second to none. If you're ready to join us at the edge of something unstoppable, let's make a profound impact together for our patients, for your career, for what's beyond . You can view our latest corporate deck and other presentations here . About the Role >>> Associate Director, Analytical Development As the Associate Director of Analytical Development reporting to the Senior Director of Analytical Chemistry you will be responsible for driving progress of both early and late-stage molecules by delivering phase - appropriate analytical methods, validation and tech transfers. You will partner with cross-functionally supporting process development, formulations, CMC, and quality activities. In addition, you will bring demonstrated team playing and collaboration skills and experience operating effectively in a fast-paced, growth-stage biotech environment. This role can be based out of our San Francisco, CA or Boston, MA office and will require 10-15% travel . Your work will primarily encompass: Supporting analytical method development,
---
TITLE: Vice President, Market Access
EMPLOYER: Olema Pharmaceuticals
LOCATION: San Francisco, California (unspecified)
SALARY: $300K-$350K
POSTED: 2026-06-04
APPLY_URL: https://job-boards.greenhouse.io/olema/jobs/5841388004
EXCERPT: Vice President, Market Access San Francisco, California Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breast cancer with blockbuster potential as a monotherapy and in combination in ER+/HER2- metastatic breast cancer. Our follow-on product candidate, OP-3136, is a potent KAT6 inhibitor with best-in-class potential. Our scientific breakthroughs are accelerated through the ways in which we fearlessly support, motivate, and challenge one another. At Olema, we know that when we put people first, our work becomes second to none. If you're ready to join us at the edge of something unstoppable, let's make a profound impact together for our patients, for your career, for what's beyond . You can view our latest corporate deck and other presentations here . About the Role >>> Vice President, Market Access As the Vice President of Market Access, you will build and lead the market access organization and capabilities critical to Olema's mission to bring better medicines to breast cancer patients. This leader will have a significant role in preparing the company and the market for the launch of Olema's lead product, palazestrant, a novel SERD/CERAN being evaluated in ER+ HER2- metastatic breast cancer. The leadership scope spans all aspects of U.S. market access-payor and account engagement, pricing, coverage and reimbursement, distribution, and patient support programs. The ideal candidate brings deep market access expertise in oral oncology therapeutics and has demonstrated success building
---
TITLE: Associate Director, Clinical Supply Chain
EMPLOYER: Olema Pharmaceuticals
LOCATION: Boston, Massachusetts (unspecified)
SALARY: $185K-$200K
POSTED: 2026-06-04
APPLY_URL: https://job-boards.greenhouse.io/olema/jobs/5818437004
EXCERPT: Associate Director, Clinical Supply Chain Boston, Massachusetts Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breast cancer with blockbuster potential as a monotherapy and in combination in ER+/HER2- metastatic breast cancer. Our follow-on product candidate, OP-3136, is a potent KAT6 inhibitor with best-in-class potential. Our scientific breakthroughs are accelerated through the ways in which we fearlessly support, motivate, and challenge one another. At Olema, we know that when we put people first, our work becomes second to none. If you're ready to join us at the edge of something unstoppable, let's make a profound impact together for our patients, for your career, for what's beyond . You can view our latest corporate deck and other presentations here . About the Role >>> Associate Director, Clinical Supply Chain As the Associate Director of Clinical Supply Chain reporting to the Vice President, Clinical Supply Chain, you will plan, create, implement, build, and optimize the clinical supply chain to ensure uninterrupted and timely clinical drug supply for Olema's clinical programs. This role is available in either our San Francisco or Cambridge office and will require about 15% domestic or international travel. Your work will primarily encompass: End to End clinical supply chain management Develop and implement global Clinical Supply Chain strategies Manage global inventories, shipping, and third-party manufacturers / logistics providers Develop and manage Interactive Response Technologies (IRT) systems Oversight packaging,
---
TITLE: Vice President Quality Assurance
EMPLOYER: Olema Pharmaceuticals
LOCATION: Boston, Massachusetts (unspecified)
SALARY: $315K-$340K
POSTED: 2026-06-04
APPLY_URL: https://job-boards.greenhouse.io/olema/jobs/5977235004
EXCERPT: Vice President Quality Assurance Boston, Massachusetts Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breast cancer with blockbuster potential as a monotherapy and in combination in ER+/HER2- metastatic breast cancer. Our follow-on product candidate, OP-3136, is a potent KAT6 inhibitor with best-in-class potential. Our scientific breakthroughs are accelerated through the ways in which we fearlessly support, motivate, and challenge one another. At Olema, we know that when we put people first, our work becomes second to none. If you're ready to join us at the edge of something unstoppable, let's make a profound impact together for our patients, for your career, for what's beyond . You can view our latest corporate deck and other presentations here . About the Role >>> Vice President, Quality Assurance The Vice President, Quality Assurance serves as the senior leader accountable for defining and driving Olema's global quality strategy, systems, and governance across the full product lifecycle, including clinical development, manufacturing, pharmacovigilance, and commercial. This leader is the primary voice of Quality at the executive level and ensures a phase-appropriate, risk-based approach to quality that reflects the needs of oncology drug development, where patient safety, data integrity, and speed are critical. Operating with appropriate independence, this role partners cross-functionally and leads an established Quality leadership team across GCP, GMP, and GPV - aligning priorities, strengthening execution, and ensuring inspection readiness as Olema advances
---
TITLE: Senior Manager, Legal Operations & Contracts
EMPLOYER: Olema Pharmaceuticals
LOCATION: San Francisco, California (unspecified)
SALARY: $150K-$170K
POSTED: 2026-06-04
APPLY_URL: https://job-boards.greenhouse.io/olema/jobs/5977366004
EXCERPT: Senior Manager, Legal Operations & Contracts San Francisco, California Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breast cancer with blockbuster potential as a monotherapy and in combination in ER+/HER2- metastatic breast cancer. Our follow-on product candidate, OP-3136, is a potent KAT6 inhibitor with best-in-class potential. Our scientific breakthroughs are accelerated through the ways in which we fearlessly support, motivate, and challenge one another. At Olema, we know that when we put people first, our work becomes second to none. If you're ready to join us at the edge of something unstoppable, let's make a profound impact together for our patients, for your career, for what's beyond . You can view our latest corporate deck and other presentations here . About the Role >>> Senior Manager, Legal Operations & Contracts As the Senior Manager, Legal Operations & Contracts reporting to the Vice-President, Legal Counsel, you will bring strong legal operations expertise, including process management, execution, compliance, and process optimization, with a focus on building and scaling efficient workflows. In addition, you bring a deep background in drafting, reviewing, and negotiating a high volume of both routine and complex contracts. This role will operate independently across functions as a trusted partner, proactively managing the end-to-end contract lifecycle for commercialization contracts while driving operational excellence and efficiency. This role will support the legal team through KPI tracking, metrics, and analysis,
---
TITLE: Director, CMC Drug Substance Manufacturing
EMPLOYER: Olema Pharmaceuticals
LOCATION: Dublin, Ireland (unspecified)
SALARY: Not disclosed
POSTED: 2026-06-04
APPLY_URL: https://job-boards.greenhouse.io/olema/jobs/5840034004
EXCERPT: Director, CMC Drug Substance Manufacturing Dublin, Ireland Olema Oncology is dedicated to developing better medicines for breast cancer and beyond. Our lead program, palazestrant (OP-1250), is a complete estrogen receptor antagonist (CERAN) currently in development for metastatic breast cancer with blockbuster potential as a monotherapy and in combination in ER+/HER2- metastatic breast cancer. Our follow-on product candidate, OP-3136, is a potent KAT6 inhibitor with best-in-class potential. Our scientific breakthroughs are accelerated through the ways in which we fearlessly support, motivate, and challenge one another. At Olema, we know that when we put people first, our work becomes second to none. If you're ready to join us at the edge of something unstoppable, let's make a profound impact together for our patients, for your career, for what's beyond . You can view our latest corporate deck and other presentations here . About the Role >>> Director, CMC Drug Substance Manufacturing As the Director, CMC Drug Substance Manufacturing reporting to the Sr Director, Drug Substance Development and Manufacturing, you will provide technical leadership and hands-on execution to support late-stage development, technology transfer to CDMOs, and commercial readiness including NDA filing for small molecule drug substances. This role is critical to ensuring successful scale-up, validation, and regulatory approval of drug substance processes. The individual will work cross-functionally and externally with CDMOs to deliver robust, compliant, and efficient manufacturing processes suitable for commercial supply. This role is based out of our Dublin, Ireland office and will require 10-15% travel. Your work will primarily encompass:
---
TITLE: Associate Strategic Accounts Director, Pharma and Biotech
EMPLOYER: Ultima Genomics
LOCATION: Remote US (remote)
SALARY: $150K-$200K
POSTED: 2026-03-07
MENTAL_HEALTH_SUPPORT: yes (not source-backed)
APPLY_URL: https://job-boards.greenhouse.io/ultimagenomics/jobs/5821432004
EXCERPT: Associate Strategic Accounts Director, Pharma and Biotech Remote US Rapidly Growing Life Sciences Technology Company Ultima Genomics is a rapidly growing company that is developing ground-breaking genomics technologies. Our mission is to continuously drive the scale of genomic information to enable unprecedented advances in biology and improvements in human health. We have developed a foundational new approach to sequencing at scale that overcomes limitations due to the high costs of current technologies. We are well-funded and have raised approximately $600 million from global top-tier investors. Our team brings together unique and diverse expertise across multiple disciplines, from healthcare and life sciences, to engineering, to technology and software and beyond. We are a collaborative group, including successful entrepreneurs, chemists, hardware and software engineers, genomics and biotechnology experts, molecular and computational biologists, software and algorithm experts, and operations and commercial leaders. Join us to develop and commercialize technologies that unleash the power of genomics at scale and empower the future of human health. We are looking for a highly motivated Associate Strategic Accounts Director, Pharma and Biotech to join our team! You will be a key member of the Strategic Accounts team supporting the VP, Finance and Business Development in executing Ultima's strategy in enabling large-scale data generation and engaging with biotech and pharma accounts. Experience in the life science tools or pharma-services space with a consistent track record of commercial success is highly preferred. This role will report to the VP, Finance and Business Development. How You'll Contribute - Act as
---
TITLE: Pharmaceutical Sciences, Technology & Innovation Lead (Sr. Director)
EMPLOYER: Takeda Pharmaceutical Company Limited
LOCATION: Boston, MA (unspecified)
SALARY: Not disclosed
POSTED: 2026-06-11
K401_MATCH: yes (not source-backed)
APPLY_URL: https://takeda.wd3.myworkdayjobs.com/External/job/Boston-MA/Pharmaceutical-Sciences--Technology---Innovation-Lead--Sr-Director-_R0178501-1
EXCERPT: Pharmaceutical Sciences, Technology & Innovation Lead (Sr. Director) Boston, MA posted: Posted Yesterday
---
TITLE: Pharmaceutical Sciences, Operations & Performance Lead (Sr. Director)
EMPLOYER: Takeda Pharmaceutical Company Limited
LOCATION: Boston, MA (unspecified)
SALARY: Not disclosed
POSTED: 2026-05-12
K401_MATCH: yes (not source-backed)
APPLY_URL: https://takeda.wd3.myworkdayjobs.com/External/job/Boston-MA/Pharmaceutical-Sciences--Strategy---Operations-Lead--Sr-Director-_R0178498
EXCERPT: Pharmaceutical Sciences, Operations & Performance Lead (Sr. Director) Boston, MA posted: Posted 30+ Days Ago
---
TITLE: Principal or Associate Scientist, Analytical Development Japan (Late Stage), Pharmaceutical Sciences
EMPLOYER: Takeda Pharmaceutical Company Limited
LOCATION: Fujisawa, Japan (unspecified)
SALARY: Not disclosed
POSTED: 2026-06-12
K401_MATCH: yes (not source-backed)
APPLY_URL: https://takeda.wd3.myworkdayjobs.com/External/job/Fujisawa-Japan/Principal-or-Associate-Scientist--Analytical-Development-Japan--Late-Stage---Pharmaceutical-Sciences_R0181177-1
EXCERPT: Principal or Associate Scientist, Analytical Development Japan (Late Stage), Pharmaceutical Sciences Fujisawa, Japan posted: Posted Today
---
TITLE: Principal or Associate Scientist, Analytical Development Japan, Pharmaceutical Sciences
EMPLOYER: Takeda Pharmaceutical Company Limited
LOCATION: Fujisawa, Japan (unspecified)
SALARY: Not disclosed
POSTED: 2026-05-12
K401_MATCH: yes (not source-backed)
APPLY_URL: https://takeda.wd3.myworkdayjobs.com/External/job/Fujisawa-Japan/Principal-or-Associate-Scientist--Analytical-Development-Japan--Pharmaceutical-Sciences_R0177837-1
EXCERPT: Principal or Associate Scientist, Analytical Development Japan, Pharmaceutical Sciences Fujisawa, Japan posted: Posted 30+ Days Ago
---
TITLE: Associate Director or Principal Scientist, Facility Operations, Pharmaceutical Sciences
EMPLOYER: Takeda Pharmaceutical Company Limited
LOCATION: Fujisawa, Japan (unspecified)
SALARY: Not disclosed
POSTED: 2026-05-12
K401_MATCH: yes (not source-backed)
APPLY_URL: https://takeda.wd3.myworkdayjobs.com/External/job/Fujisawa-Japan/Associate-Director-or-Principal-Scientist--Facility-Operations--Pharmaceutical-Sciences_R0178525-1
EXCERPT: Associate Director or Principal Scientist, Facility Operations, Pharmaceutical Sciences Fujisawa, Japan posted: Posted 30+ Days Ago
---
TITLE: Senior Specialist, Regulatory Operations
EMPLOYER: Tonix Pharmaceuticals Holding Corp
LOCATION: Frederick, MD (unspecified)
SALARY: $70K-$130K
POSTED: 2026-01-15
K401_MATCH: yes (not source-backed)
APPLY_URL: https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4106035009
EXCERPT: Senior Specialist, Regulatory Operations Frederick, MD Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview The Senior Specialist, Regulatory Operations, will
---
TITLE: Pharmaceutical Technician II
EMPLOYER: Thermo Fisher Scientific
LOCATION: Singapore, Singapore (unspecified)
SALARY: Not disclosed
POSTED: 2026-06-11
K401_MATCH: yes (not source-backed)
APPLY_URL: https://thermofisher.wd5.myworkdayjobs.com/ThermoFisherCareers/job/Singapore-Singapore/Pharmaceutical-Technician-II_R-01354187/apply
EXCERPT: Pharmaceutical Technician II Singapore, Singapore Embrace the role of a Pharmaceutical Technician II and play a vital role in sterile pharmaceutical production. Operate advanced equipment, ensure GMP compliance, and support quality manufacturing processes. If you have hands-on experience in pharmaceutical manufacturing and a passion for safety and precision, this is your opportunity to make an impact.
---
TITLE: Pharmaceutical Technician II
EMPLOYER: Thermo Fisher Scientific
LOCATION: Singapore, Singapore (unspecified)
SALARY: Not disclosed
POSTED: 2026-06-11
K401_MATCH: yes (not source-backed)
APPLY_URL: https://thermofisher.wd5.myworkdayjobs.com/ThermoFisherCareers/job/Singapore-Singapore/Pharmaceutical-Technician-II_R-01349946-1/apply
EXCERPT: Pharmaceutical Technician II Singapore, Singapore Embrace the role of a Pharmaceutical Technician II and play a vital role in sterile pharmaceutical production. Operate advanced equipment, ensure GMP compliance, and support quality manufacturing processes. Ideal for candidates with 1-5 years' experience in pharma, this role offers hands-on work in a dynamic, safety-focused environment. Grow your career in pharmaceutical manufacturing today!
---
TITLE: Pharmaceutical Technician II
EMPLOYER: Thermo Fisher Scientific
LOCATION: Singapore, Singapore (unspecified)
SALARY: Not disclosed
POSTED: 2026-06-11
K401_MATCH: yes (not source-backed)
APPLY_URL: https://thermofisher.wd5.myworkdayjobs.com/ThermoFisherCareers/job/Singapore-Singapore/Pharmaceutical-Technician-II_R-01340678/apply
EXCERPT: Pharmaceutical Technician II Singapore, Singapore Embrace the role of a Pharmaceutical Technician II and play a vital role in sterile pharmaceutical production. Operate advanced equipment, ensure GMP compliance, and contribute to quality manufacturing. If you have hands-on experience in pharma production and a passion for safety and precision, this is your opportunity to make a difference.
---
TITLE: Lead Director, Pharmaceutical Contracting
EMPLOYER: CVS Health Corporation
LOCATION: Work at Home, Illinois, United States (unspecified)
SALARY: Not disclosed
POSTED: 2026-06-10
NON_BIRTH_PARENT_LEAVE_WEEKS: 4 (not source-backed)
K401_MATCH: yes (not source-backed)
APPLY_URL: https://cvshealth.wd1.myworkdayjobs.com/CVS_Health_Careers/job/IL---Downers-Grove/Lead-Director--Pharmaceutical-Contracting_R0933942/apply
EXCERPT: Lead Director, Pharmaceutical Contracting Work at Home, Illinois, United States Join us as Lead Director, Pharmaceutical Contracting and drive high-impact negotiations with major pharmaceutical manufacturers. Shape strategy, foster partnerships, and lead rebate initiatives in a dynamic healthcare environment. If you excel in complex contract negotiations and thrive in leadership roles, this is your opportunity to make a significant impact.
---
TITLE: Senior Manager, Total Rewards
EMPLOYER: Tonix Pharmaceuticals Holding Corp
LOCATION: Berkeley Heights, NJ (unspecified)
SALARY: $130K-$170K
POSTED: 2026-05-05
K401_MATCH: yes (not source-backed)
APPLY_URL: https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4239809009
EXCERPT: Senior Manager, Total Rewards Berkeley Heights, NJ Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview The Senior Manager, Total Rewards
---
TITLE: Pharmaceutical Technician II
EMPLOYER: Thermo Fisher Scientific
LOCATION: Singapore, Singapore (unspecified)
SALARY: Not disclosed
POSTED: 2026-06-11
K401_MATCH: yes (not source-backed)
APPLY_URL: https://thermofisher.wd5.myworkdayjobs.com/ThermoFisherCareers/job/Singapore-Singapore/Pharmaceutical-Technician-II_R-01340680-1/apply
EXCERPT: Pharmaceutical Technician II Singapore, Singapore Embrace the opportunity to become a Pharmaceutical Technician II and play a vital role in sterile pharmaceutical production. Operate advanced equipment, ensure GMP compliance, and contribute to quality manufacturing. If you have hands-on experience in pharma production and a passion for safety and precision, this is your opportunity to make a difference.
---
TITLE: Senior Director of CMC and Nonclinical Program Management
EMPLOYER: Tonix Pharmaceuticals Holding Corp
LOCATION: North Dartmouth, MA (unspecified)
SALARY: $224K-$280K
POSTED: 2026-03-19
K401_MATCH: yes (not source-backed)
APPLY_URL: https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4186570009
EXCERPT: Senior Director of CMC and Nonclinical Program Management North Dartmouth, MA Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview Tonix
---
TITLE: Thought Leader Liaison (TLL), West Region
EMPLOYER: Tonix Pharmaceuticals Holding Corp
LOCATION: United States (unspecified)
SALARY: $130K-$200K
POSTED: 2026-02-12
K401_MATCH: yes (not source-backed)
APPLY_URL: https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4130652009
EXCERPT: Thought Leader Liaison (TLL), West Region United States Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview The Associate Director, Thought
---
TITLE: Manager, Corporate Strategy and CEO Initiatives
EMPLOYER: Tonix Pharmaceuticals Holding Corp
LOCATION: Berkeley Heights, NJ (unspecified)
SALARY: $90K-$150K
POSTED: 2026-06-04
K401_MATCH: yes (not source-backed)
APPLY_URL: https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4272302009
EXCERPT: Manager, Corporate Strategy and CEO Initiatives Berkeley Heights, NJ Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview The Manager, Corporate
---
TITLE: VP, Clinical Development - Infectious Disease
EMPLOYER: Tonix Pharmaceuticals Holding Corp
LOCATION: Frederick, Maryland or Berkeley Heights, New Jersey (unspecified)
SALARY: $250K-$350K
POSTED: 2026-01-20
K401_MATCH: yes (not source-backed)
APPLY_URL: https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4108447009
EXCERPT: VP, Clinical Development - Infectious Disease Frederick, Maryland or Berkeley Heights, New Jersey Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position
---
TITLE: Manager, Trade & Market Access
EMPLOYER: Tonix Pharmaceuticals Holding Corp
LOCATION: Berkeley Heights, NJ (unspecified)
SALARY: $90K-$150K
POSTED: 2026-03-05
K401_MATCH: yes (not source-backed)
APPLY_URL: https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4170833009
EXCERPT: Manager, Trade & Market Access Berkeley Heights, NJ Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview The Manager of Trade
---
TITLE: Pharmaceutical Sales Specialist Immunology - Alsace
EMPLOYER: Regeneron Pharmaceuticals
LOCATION: Remote - France (remote)
SALARY: Not disclosed
POSTED: 2026-06-08
PARENTAL_LEAVE_WEEKS: 12 (not source-backed)
NON_BIRTH_PARENT_LEAVE_WEEKS: 12 (not source-backed)
K401_MATCH: yes (not source-backed)
APPLY_URL: https://regeneron.wd1.myworkdayjobs.com/Careers/job/Remote---France/Pharmaceutical-Sales-Specialist-Immunology---Alsace_R47580
EXCERPT: Pharmaceutical Sales Specialist Immunology - Alsace Remote - France posted: Posted 4 Days Ago
---
TITLE: Senior Manager, Cost Accounting
EMPLOYER: Tonix Pharmaceuticals Holding Corp
LOCATION: Berkeley Heights, NJ or Frederick, MD or North Dartmouth, MA (unspecified)
SALARY: $100K-$150K
POSTED: 2026-05-21
K401_MATCH: yes (not source-backed)
APPLY_URL: https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4248421009
EXCERPT: Senior Manager, Cost Accounting Berkeley Heights, NJ or Frederick, MD or North Dartmouth, MA Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners.
---
TITLE: Manager, Quality Systems & Administration
EMPLOYER: Tonix Pharmaceuticals Holding Corp
LOCATION: North Dartmouth, MA (unspecified)
SALARY: $110K-$145K
POSTED: 2026-04-13
K401_MATCH: yes (not source-backed)
APPLY_URL: https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4214661009
EXCERPT: Manager, Quality Systems & Administration North Dartmouth, MA Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview: The Manager, Quality Systems
---
TITLE: Senior Product Manager
EMPLOYER: Ophelia
LOCATION: United States (unspecified)
SALARY: $190K-$200K
POSTED: 2025-11-03
APPLY_URL: https://job-boards.greenhouse.io/ophelia/jobs/4973748008
EXCERPT: Senior Product Manager United States Are you looking for a role in a company that's solving one of the greatest challenges of our lifetime? Ophelia helps people end their opioid use and restore their quality of life with respect for their time and dignity. Our mission is to make evidence-based treatments for opioid use disorder (OUD) accessible to everyone... and we're looking to bring more people onto our team to help us achieve it. Ophelia is a venture-backed, healthcare startup that helps individuals with OUD by providing FDA-approved medication and clinical care through a telehealth platform. Our approach is discreet, convenient, and affordable. We've been successfully operating in 14 states for almost six years and we're excited to continue our growth. We are a team of physicians, scientists, entrepreneurs, researchers and White House advisors, backed by leading technology and healthcare investors working to re-imagine and re-build OUD treatment in America. About The Role As a Senior Product Manager , you will create industry-leading digital products that prove telehealth to be the best way to treat opioid use disorder! You will be shaping our product strategy, aligning stakeholders, and shipping valuable digital products. You will be a leader on one of our product teams and will work cross-functionally with patients, clinicians, operators, marketers, billers, and more (this role is perfect if you want to fully immerse in technology-enabled, healthcare services). Together, you will facilitate collaboration among these stakeholders to identify problems and explore solutions in an iterative way. You will work
---
TITLE: Director, Commercial Operations and Analytics
EMPLOYER: Tonix Pharmaceuticals Holding Corp
LOCATION: Berkeley Heights, NJ (unspecified)
SALARY: $180K-$230K
POSTED: 2025-12-15
K401_MATCH: yes (not source-backed)
APPLY_URL: https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4077936009
EXCERPT: Director, Commercial Operations and Analytics Berkeley Heights, NJ Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview The Director, Commercial Operations
---
TITLE: Technician, Pharmaceutical
EMPLOYER: AbbVie Inc.
LOCATION: Sligo, SO, Ireland (unspecified)
SALARY: Not disclosed
POSTED: 2026-06-12
PARENTAL_LEAVE_WEEKS: 12 (not source-backed)
NON_BIRTH_PARENT_LEAVE_WEEKS: 12 (not source-backed)
K401_MATCH: yes (not source-backed)
APPLY_URL: https://jobs.smartrecruiters.com/AbbVie/3743990013577016-technician-pharmaceutical
EXCERPT: Technician, Pharmaceutical Sligo, SO, Ireland Company Description: About AbbVie AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology and neuroscience - and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com . Follow @abbvie on LinkedIn, Facebook , Instagram , X and YouTube. Job Description: We are recruiting a Pharmaceutical Technician to join our team on site in Manorhamilton Road, Sligo on a 12 month fixed-term contract. This role is rotational shift work. In your role as Pharmaceutical Technician you will be responsible for producing drug product materials as per organizational needs in line with all relevant compliance requirements. This person will operate as a team member in a pharmaceutical processing facility in line with all regulatory and organizational requirements. A snapshot of your key responsibilities as a Pharmaceutical Technician would be: Pharmaceutical processing activities in our manufacturing building and support locations. Team co-ordination to maximise the effectiveness of the team members. Documentation of all activities in line with cGMP requirements. Cross training within the team and training of new team members. Participation in continuous improvement programs to implement improvements in the quality, safety, environmental and production systems. Execution of commissioning and validation protocols on an ongoing basis. Maintaining the overall cGMP of the pharmaceutical processing areas. Adheres
---
TITLE: Scientist II, Animal Model Development
EMPLOYER: Tonix Pharmaceuticals Holding Corp
LOCATION: Frederick, MD (unspecified)
SALARY: $70K-$120K
POSTED: 2026-03-05
K401_MATCH: yes (not source-backed)
APPLY_URL: https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4170744009
EXCERPT: Scientist II, Animal Model Development Frederick, MD Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview Tonix Research and Development Center
---
TITLE: Senior Research Associate/Senior Scientist, Pharmaceutical Development
EMPLOYER: Ionis Pharmaceuticals
LOCATION: 2280 Faraday-USA; 2830 Whiptail (unspecified)
SALARY: Not disclosed
POSTED: 2026-06-05
K401_MATCH: yes (not source-backed)
APPLY_URL: https://recruiting.ultipro.com/isi1000isis/JobBoard/14a66400-68fa-4847-8593-af776328cfd2/OpportunityDetail?opportunityId=ad2d13f5-0499-4011-b6d6-e4be422f0485
EXCERPT: Senior Research Associate/Senior Scientist, Pharmaceutical Development 2280 Faraday-USA; 2830 Whiptail Ionis Pharmaceuticals seeks an experienced pharmaceutical development scientist to support laboratory experiments, review development data, and author and standardize technical reports for injectable drug products in development. The ideal candidate will be an independent self-starter with experience in analytical, formulation and process support for early and late-stage development of oligonucleotide-based drug products including conjugated with small molecules, peptides and proteins. The successful candidate will be able to perform the following responsibilities with a high degree of independence and attention to detail.
---
TITLE: Manager, FP&A, Europe
EMPLOYER: Revolution Medicines
LOCATION: Basel, Basel-Stadt, Switzerland (unspecified)
SALARY: Not disclosed
POSTED: 2026-06-04
K401_MATCH: yes (not source-backed)
APPLY_URL: https://www.revmed.com/careers-list/?gh_jid=7763991003
EXCERPT: Manager, FP&A, Europe Basel, Basel-Stadt, Switzerland Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Manager, FP&A Europe will support the Sr Director FP&A Europe in driving financial planning, reporting, business analytics, and operational execution across the European region as the company prepares for commercial growth. Based in Basel, Switzerland, this role will coordinate budgeting and forecasting activities, deliver financial insights, support reporting and planning tools, and help ensure efficient day-to-day finance operations across European affiliates and functions. The ideal candidate is analytical, hands-on, highly organized, and comfortable operating in a fast-paced biotech environment. Support FP&A & Financial Operations - Support annual budget, quarterly forecast, and long-range planning processes across Europe. - Coordinate planning timelines, templates, and data collection with regional stakeholders. - Assist in maintaining European management P&L structures by country, function, and product. - Prepare monthly Actuals vs. Budget / Forecast reporting and variance analyses. - Consolidate and validate financial submissions from affiliates and functions. - Support OpEx
---
TITLE: Senior Legal Counsel - Pharmaceutical Contracting
EMPLOYER: CVS Health Corporation
LOCATION: One CVS Drive, Woonsocket, Rhode Island,United States (unspecified)
SALARY: Not disclosed
POSTED: 2026-05-26
NON_BIRTH_PARENT_LEAVE_WEEKS: 4 (not source-backed)
K401_MATCH: yes (not source-backed)
APPLY_URL: https://cvshealth.wd1.myworkdayjobs.com/CVS_Health_Careers/job/RI---Woonsocket/Senior-Legal-Counsel---Pharmaceutical-Contracting_R0901888/apply
EXCERPT: Senior Legal Counsel - Pharmaceutical Contracting One CVS Drive, Woonsocket, Rhode Island,United States Join our team as a Senior Legal Counsel - Pharmaceutical Contracting and play a pivotal role in shaping healthcare solutions. Advise on complex retail trade and pharmaceutical agreements, ensure regulatory compliance, and collaborate with cross-functional teams. Make a meaningful impact in a dynamic environment dedicated to innovation and patient care.
---
TITLE: Sr. Director, Brand Marketing
EMPLOYER: Tonix Pharmaceuticals Holding Corp
LOCATION: Berkeley Heights, NJ (unspecified)
SALARY: $190K-$285K
POSTED: 2026-04-24
K401_MATCH: yes (not source-backed)
APPLY_URL: https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4227536009
EXCERPT: Sr. Director, Brand Marketing Berkeley Heights, NJ Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview The Senior Director, Brand Marketing
---
TITLE: Pharmaceutical Assistant
EMPLOYER: Pfizer
LOCATION: United States - Kansas - McPherson (unspecified)
SALARY: Not disclosed
POSTED: 2026-06-12
PARENTAL_LEAVE_WEEKS: 12 (not source-backed)
NON_BIRTH_PARENT_LEAVE_WEEKS: 12 (not source-backed)
K401_MATCH: yes (not source-backed)
APPLY_URL: https://pfizer.wd1.myworkdayjobs.com/PfizerCareers/job/United-States---Kansas---McPherson/Pharmaceutical-Assistant_4954329-1
EXCERPT: Pharmaceutical Assistant United States - Kansas - McPherson posted: Posted Today
---
TITLE: Field Reimbursement Manager (FRM), Endocrinology - Gulf Coast/Mississippi
EMPLOYER: Corcept Therapeutics
LOCATION: Gulf Coast/Mississippi, United States (unspecified)
SALARY: $154K-$200K
POSTED: 2026-05-29
K401_MATCH: yes (not source-backed)
APPLY_URL: https://www.corcept.com/careers/current-opportunities/?gh_jid=6009531004
EXCERPT: Field Reimbursement Manager (FRM), Endocrinology - Gulf Coast/Mississippi Gulf Coast/Mississippi, United States For more than 25 years, Corcept has been singularly focused on the science of cortisol, a powerful hormone that when unregulated, can play a role in a broad range of diseases. Our commercial portfolio includes treatments for hypercortisolism and oncology, and the company has discovered more than 1,000 proprietary selective cortisol modulators and glucocorticoid receptor antagonists. With advanced clinical trials in patients with hypercortisolism, solid tumors, ALS and liver disease, Corcept is unlocking the power of cortisol modulation to help address some of the most devastating diseases patients face today. Corcept is headquartered in Redwood City, California. To learn more, visit www.corcept.com . The Field Reimbursement Manager (FRM), Endocrinology plays a critical role in ensuring that patients who need our therapies can access them, efficiently, reliably, and with the support they deserve. This role serves as the subject matter expert on access and reimbursement for Korlym, Mifepristone AG, and Relacorilant, supporting healthcare providers (HCPs), field sales teams, specialty pharmacies (SPs), and our patient support HUB to resolve barriers to patient access. The FRM will deliver education, troubleshoot complex reimbursement challenges, and work collaboratively across functions to ensure successful initiation and continuation of therapy for appropriate patients. FRMs are natural problem-solvers and relationship-builders who thrives in a dynamic, patient-centric environment. They bring deep knowledge of the access landscape and excel at navigating payer policies, benefits verifications, prior authorizations, and reimbursement and access logistics. Responsibilities: Support Patient Access & Pull-Through
---
TITLE: Pharmaceutical Attendant
EMPLOYER: Pfizer
LOCATION: United States - Kansas - McPherson (unspecified)
SALARY: Not disclosed
POSTED: 2026-06-11
PARENTAL_LEAVE_WEEKS: 12 (not source-backed)
NON_BIRTH_PARENT_LEAVE_WEEKS: 12 (not source-backed)
K401_MATCH: yes (not source-backed)
APPLY_URL: https://pfizer.wd1.myworkdayjobs.com/PfizerCareers/job/United-States---Kansas---McPherson/Pharmaceutical-Attendant_4956657-1
EXCERPT: Pharmaceutical Attendant United States - Kansas - McPherson posted: Posted Yesterday
---
TITLE: Director, Oncology Market Access Marketing
EMPLOYER: AbbVie Inc.
LOCATION: Florham Park, NJ, United States (unspecified)
SALARY: Not disclosed
POSTED: 2026-06-10
PARENTAL_LEAVE_WEEKS: 12 (not source-backed)
NON_BIRTH_PARENT_LEAVE_WEEKS: 12 (not source-backed)
K401_MATCH: yes (not source-backed)
APPLY_URL: https://jobs.smartrecruiters.com/AbbVie/3743990013458596--director-oncology-market-access-marketing
EXCERPT: Director, Oncology Market Access Marketing Florham Park, NJ, United States Company Description: About AbbVie AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology and neuroscience - and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com . Follow @abbvie on LinkedIn, Facebook , Instagram , X and YouTube. Job Description: AbbVie is looking for a Director of Oncology US Market Access Marketing, ETENTA. This position is responsible for market access marketing leadership for ETENTA (etentamig), a bispecific antibody in development for Multiple Myeloma. ETENTA is in late-stage clinical trials and would represent AbbVie's first launch in Multiple Myeloma, a key strategic priority for the enterprise. The Oncology Market Access Marketing Director for ETENTA will be accountable for market access marketing strategy across all payer channels, including Commercial, Medicare, Medicaid, VA, and other relevant access segments, as well as key account and community oncology channels, as applicable. This role will lead strategic alignment with Market Access field teams and coordinate strategy, communication, and alignment across US Market Access channel and policy partners, the Oncology Commercial Organization, and US Medical Affairs. As the market access marketing subject matter expert for the ETENTA Integrated Brand Team, the Director will develop market access strategies and tactics that support brand objectives and reflect
---
TITLE: Pharmaceutical Process Expert (PPE)
EMPLOYER: Ipsen
LOCATION: Wrexham (unspecified)
SALARY: Not disclosed
POSTED: 2026-05-12
K401_MATCH: yes (not source-backed)
APPLY_URL: https://ipsen.wd103.myworkdayjobs.com/Ipsen_Careers/job/Wrexham/Pharmaceutical-Process-Expert--PPE-_R-21479
EXCERPT: Pharmaceutical Process Expert (PPE) Wrexham posted: Posted 30+ Days Ago
---
TITLE: Director, Regulatory Affairs - Infectious Disease
EMPLOYER: Tonix Pharmaceuticals Holding Corp
LOCATION: Berkeley Heights, NJ (unspecified)
SALARY: $150K-$240K
POSTED: 2026-03-11
K401_MATCH: yes (not source-backed)
APPLY_URL: https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4180874009
EXCERPT: Director, Regulatory Affairs - Infectious Disease Berkeley Heights, NJ Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview The Director, Regulatory
---
TITLE: Account Manager - Pharmaceutical
EMPLOYER: Amcor
LOCATION: 16 Locations (unspecified)
SALARY: Not disclosed
POSTED: 2026-05-12
K401_MATCH: yes (not source-backed)
APPLY_URL: https://amcor.wd5.myworkdayjobs.com/Amcor_External_Career_Site/job/AF-Deerfield-IL-Corporate/Account-Manager---Pharmaceutical_REQ_89081
EXCERPT: Account Manager - Pharmaceutical 16 Locations posted: Posted 30+ Days Ago
---
TITLE: M23 Pharmaceutical Attendant
EMPLOYER: Pfizer
LOCATION: United States - Kansas - McPherson (unspecified)
SALARY: Not disclosed
POSTED: 2026-06-11
PARENTAL_LEAVE_WEEKS: 12 (not source-backed)
NON_BIRTH_PARENT_LEAVE_WEEKS: 12 (not source-backed)
K401_MATCH: yes (not source-backed)
APPLY_URL: https://pfizer.wd1.myworkdayjobs.com/PfizerCareers/job/United-States---Kansas---McPherson/M23-Pharmaceutical-Attendant_4956770-2
EXCERPT: M23 Pharmaceutical Attendant United States - Kansas - McPherson posted: Posted Yesterday
---
TITLE: Senior Manager, Marketing Analytics - Derm
EMPLOYER: AbbVie Inc.
LOCATION: Mettawa, IL, United States (unspecified)
SALARY: Not disclosed
POSTED: 2026-06-10
PARENTAL_LEAVE_WEEKS: 12 (not source-backed)
NON_BIRTH_PARENT_LEAVE_WEEKS: 12 (not source-backed)
K401_MATCH: yes (not source-backed)
APPLY_URL: https://jobs.smartrecruiters.com/AbbVie/3743990013187274-senior-manager-marketing-analytics-derm-
EXCERPT: Senior Manager, Marketing Analytics - Derm Mettawa, IL, United States Company Description: About AbbVie AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology and neuroscience - and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com . Follow @abbvie on LinkedIn, Facebook , Instagram , X and YouTube. Job Description: AbbVie's Dermatology Franchise is seeking Senior Manager to support Sales and Marketing initiatives by delivering end-to-end analysis, insights, and recommendations that shape brand strategy and drive measurable business performance. This role translates complex physician, patient, account, and competitive data into clear narratives and actionable strategic and tactical adjustments. A successful candidate will proactively define business questions, apply rigorous analytical and modeling methodologies, and communicate concise, decision-ready insights to a broad set of stakeholders. Success requires strong business acumen, strong people and influencing skills, and close partnership with Brand and Sales Leadership to align priorities and support the current and future dermatology portfolio. Major Responsibilities: Analyze physician, account, patient, and competitive data at national and sub-national levels to strengthen the brand team's understanding of market dynamics and opportunities Lead fast-paced ad-hoc analytics projects, including taking initiative to identify the key business questions relative to product performance, that inform strategical and tactical decision-making, as well as brand planning process, ensuring
---
TITLE: Senior Manager, Clinical Business Systems
EMPLOYER: Revolution Medicines
LOCATION: Redwood City, California, United States (unspecified)
SALARY: $164K-$205K
POSTED: 2026-04-10
K401_MATCH: yes (not source-backed)
APPLY_URL: https://www.revmed.com/careers-list/?gh_jid=7695658003
EXCERPT: Senior Manager, Clinical Business Systems Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Senior Manager, Clinical Systems is a hands-on technical leader responsible for the daily administration, support, and ongoing enhancement of core clinical systems, including eTMF and CTMS, as well as the implementation and optimization of future platforms that support clinical operations (e.g., RBQM, Study Start-Up, IRT/RTSM). This role will actively perform and oversee system configuration, user management, periodic reviews, and validation activities, ensuring systems remain compliant, reliable, and inspection ready. The individual will work closely with Clinical Operations, Data Management, Regulatory, CSV, Quality, and external vendors to support business needs while maintaining GxP compliance. Key responsibilities in this role include: - Act as the hands-on system owner/lead for assigned clinical systems, supporting daily operations and issue resolution. - Perform user lifecycle management activities including provisioning, modifications, deactivation, and role-based access control. - Execute and document periodic user access reviews and audit trail
---
TITLE: Senior Analyst - Pharmaceutical Markets
EMPLOYER: IQVIA
LOCATION: Madrid, Spain (unspecified)
SALARY: Not disclosed
POSTED: 2026-05-12
K401_MATCH: yes (not source-backed)
APPLY_URL: https://iqvia.wd1.myworkdayjobs.com/IQVIA/job/Madrid-Spain/Senior-Analyst---Pharmaceutical-Markets_R1537065
EXCERPT: Senior Analyst - Pharmaceutical Markets Madrid, Spain posted: Posted 30+ Days Ago
---
TITLE: Executive Director, Portfolio Management
EMPLOYER: Revolution Medicines
LOCATION: Redwood City, California, United States (unspecified)
SALARY: $265K-$331K
POSTED: 2025-04-24
K401_MATCH: yes (not source-backed)
APPLY_URL: https://www.revmed.com/careers-list/?gh_jid=6530477003
EXCERPT: Executive Director, Portfolio Management Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are looking for a highly motivated individual with experience in portfolio management, decision analysis and a passion for developing solutions for complex problems to build out this cross-functional capability and help shape our portfolio strategy. This position will report to the SVP, Development Management and Program Leadership and will be based at our headquarters in Redwood City, CA. In this highly cross functional role, you will be expected to evolve the wider portfolio management capability within Revolution Medicines and closely collaborate with Portfolio Working Group, Disease Area Teams, Program Teams, Life Cycle Teams, Analytics and Insights, Finance, Commercial and many other relevant functions. You must be entrepreneurial, able to “roll up their sleeves” and thrive in a fast-paced, highly cross-functional environment. You are an exceptional strategic and critical thinker, have a passion for interpreting and analyzing complex data, and have strong interpersonal
---
TITLE: Pharmaceutical Cleaner
EMPLOYER: AstraZeneca
LOCATION: Australia – New South Wales (unspecified)
SALARY: Not disclosed
POSTED: 2026-06-03
K401_MATCH: yes (not source-backed)
APPLY_URL: https://astrazeneca.wd3.myworkdayjobs.com/Careers/job/Australia--New-South-Wales/Pharmaceutical-Cleaner_R-251307
EXCERPT: Pharmaceutical Cleaner Australia – New South Wales posted: Posted 9 Days Ago
---
TITLE: Pharmaceutical representative
EMPLOYER: The Procter & Gamble Company
LOCATION: BUDAPEST GO - LIBERTY (unspecified)
SALARY: Not disclosed
POSTED: 2026-05-19
PARENTAL_LEAVE_WEEKS: 8 (not source-backed)
NON_BIRTH_PARENT_LEAVE_WEEKS: 8 (not source-backed)
K401_MATCH: yes (not source-backed)
APPLY_URL: https://pg.wd5.myworkdayjobs.com/1000/job/BUDAPEST-GO---LIBERTY/Pharmaceutical-representative_R000151450
EXCERPT: Pharmaceutical representative BUDAPEST GO - LIBERTY posted: Posted 24 Days Ago
---
TITLE: Senior Manager, Regulatory Affairs
EMPLOYER: Summit Therapeutics
LOCATION: Oxford (UK) (unspecified)
SALARY: EUR 80K-95K
POSTED: 2026-03-09
APPLY_URL: https://job-boards.greenhouse.io/summittherapeutics/jobs/4174479009
EXCERPT: Senior Manager, Regulatory Affairs Oxford (UK) About Summit: Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit's core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence. Summit's team is inspired to touch and help change lives through Summit's clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including: Non-small Cell Lung Cancer (NSCLC) - HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. - HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC. - HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC. Colorectal Cancer (CRC) - HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy. Ivonescimab is an
---
TITLE: Associate Scientist I, Immunology
EMPLOYER: Tonix Pharmaceuticals Holding Corp
LOCATION: Frederick, MD 21701 (unspecified)
SALARY: $50K-$70K
POSTED: 2026-05-18
K401_MATCH: yes (not source-backed)
APPLY_URL: https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4245265009
EXCERPT: Associate Scientist I, Immunology Frederick, MD 21701 Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview Tonix is seeking an Associate
---
TITLE: Graphic Designer – Pharmaceutical Marketing
EMPLOYER: Amgen
LOCATION: India - Hyderabad (unspecified)
SALARY: Not disclosed
POSTED: 2026-05-12
PARENTAL_LEAVE_WEEKS: 6 (not source-backed)
NON_BIRTH_PARENT_LEAVE_WEEKS: 6 (not source-backed)
K401_MATCH: yes (not source-backed)
APPLY_URL: https://amgen.wd1.myworkdayjobs.com/Careers/job/India---Hyderabad/Graphic-Designer---Pharmaceutical-Marketing_R-240424
EXCERPT: Graphic Designer – Pharmaceutical Marketing India - Hyderabad posted: Posted 30+ Days Ago
---
TITLE: Oncology Account Manager – Nashville
EMPLOYER: Syndax Pharmaceuticals Inc
LOCATION: New York, NY (unspecified)
SALARY: $215K-$230K
POSTED: 2026-05-28
K401_MATCH: yes (not source-backed)
APPLY_URL: https://syndax.com/join-us/careers/?gh_jid=6008393004
EXCERPT: Oncology Account Manager – Nashville New York, NY Syndax Pharmaceuticals is looking for an Oncology Account Manager - Nashville At Syndax, we are determined to realize a future in which people with cancer live longer and better than ever before. Syndax Pharmaceuticals is a commercial stage biopharmaceutical company developing an innovative pipeline of cancer therapies. PLEASE NOTE: Territory coverage includes all of Tennessee The Role: The Oncology Account Manager will serve as a critical member of the Customer Engagement Team and will have an exciting opportunity within Syndax to build on the momentum of the successful launches of our first two products. The OAM will be responsible for meeting sales targets and utilizing all available resources while tailoring them to meet the customers' needs through a deep understanding of their requirements. Behaviors that are critical for success in this role are collaboration, communication, planning, relationship building, and the ability to execute tactical initiatives and provide timely feedback. OAMs will report directly to the Regional Business Director. Key Responsibilities: The OAM will achieve territory sales by utilizing their experience too: - Holistically support and manage territory accounts by creating relationships with physicians, allied healthcare professionals (Advanced Practitioners, Nurses, Pharmacists), and business stakeholders (CFOs, Office Practice Managers, Billers, etc.) - Maintain a uniquely deep and nuanced understanding of territory, including Opinion Leaders (OL) and other influencers, treatment and utilization trends, payer and reimbursement dynamics, and competitive opportunities and challenges. - Analyze business performance: Create and execute a comprehensive territory plan. This includes
---
TITLE: Pharmaceutical CIP/COP Technical Coordinator
EMPLOYER: Ecolab
LOCATION: 3 Locations (unspecified)
SALARY: Not disclosed
POSTED: 2026-05-19
PARENTAL_LEAVE_WEEKS: 6 (not source-backed)
NON_BIRTH_PARENT_LEAVE_WEEKS: 6 (not source-backed)
K401_MATCH: yes (not source-backed)
APPLY_URL: https://ecolab.wd1.myworkdayjobs.com/Ecolab_External/job/DEU---Nordrhein-Westfalen---Monheim-am-Rhein/Pharmaceutical-CIP-COP-Technical-Coordinator_R00291546
EXCERPT: Pharmaceutical CIP/COP Technical Coordinator 3 Locations posted: Posted 24 Days Ago
---
TITLE: Pharmacovigilance Scientist
EMPLOYER: Tonix Pharmaceuticals Holding Corp
LOCATION: Berkeley Heights, NJ (unspecified)
SALARY: $124K-$170K
POSTED: 2026-04-02
K401_MATCH: yes (not source-backed)
APPLY_URL: https://job-boards.greenhouse.io/tonixpharmaceuticals/jobs/4205666009
EXCERPT: Pharmacovigilance Scientist Berkeley Heights, NJ Tonix Pharmaceuticals* is a fully integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA® (cyclobenzaprine HCl sublingual tablets 2.8 mg) is the first new treatment for fibromyalgia in adults in more than 15 years. Tonix's CNS commercial infrastructure supports its marketed products, including its acute migraine products, Zembrace® Symtouch® (sumatriptan injection 3 mg) and Tosymra® (sumatriptan nasal spray 10 mg). Tonix is investigating TONMYA® in Phase 2 clinical trials to evaluate its potential in major depressive disorder and acute stress disorder/acute stress reaction. Tonix is also advancing a pipeline of immunology programs, including TNX-4800, a Phase 2 ready long-acting human anti- Borrelia OspA monoclonal antibody (mAb) for the prevention of Lyme disease in the U.S., and TNX-1500, a Phase 2 ready third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection. In addition, the Company is progressing TNX-2900 (intranasal potentiated oxytocin), which is Phase 2 ready for the treatment of Prader-Willi syndrome, a rare disease. To learn more, visit www.tonixpharma.com and follow the Company on LinkedIn and X . *Tonix's product development candidates are investigational new drugs or biologics; their efficacy and safety have not been established and have not been approved for any indication. Zembrace SymTouch and Tosymra are registered trademarks of Tonix Medicines. TONMYA is a registered trademark of Tonix Pharma Limited. All other marks are property of their respective owners. Position Overview Tonix is seeking an experienced Pharmacovigilance Scientist
---
TITLE: Pharmaceutical Strategic Account Manager
EMPLOYER: Becton Dickinson
LOCATION: 2 Locations (unspecified)
SALARY: Not disclosed
POSTED: 2026-06-08
K401_MATCH: yes (not source-backed)
APPLY_URL: https://bdx.wd1.myworkdayjobs.com/EXTERNAL_CAREER_SITE_USA/job/USA---Massachusetts---Boston/Pharmaceutical-Strategic-Account-Manager_R-547506-1
EXCERPT: Pharmaceutical Strategic Account Manager 2 Locations posted: Posted 4 Days Ago
---
TITLE: Pharmaceutical Production Lead - All Shifts
EMPLOYER: Medline Inc.
LOCATION: Waukegan, Illinois (unspecified)
SALARY: Not disclosed
POSTED: 2026-05-14
K401_MATCH: yes (not source-backed)
APPLY_URL: https://medline.wd5.myworkdayjobs.com/Medline/job/Waukegan-Illinois/Pharmaceutical-Production-Lead---All-Shifts_R2605412
EXCERPT: Pharmaceutical Production Lead - All Shifts Waukegan, Illinois posted: Posted 29 Days Ago
---
TITLE: （高级）产品经理 - 消化道肿瘤治疗领域
EMPLOYER: Roche Holding AG
LOCATION: Shanghai, Shanghai, China's Mainland (unspecified)
SALARY: Not disclosed
POSTED: 2026-05-17
APPLY_URL: https://roche.wd3.myworkdayjobs.com/roche-ext/job/Shanghai/XMLNAME------_202605-112387/apply
EXCERPT: （高级）产品经理 - 消化道肿瘤治疗领域 Shanghai, Shanghai, China's Mainland Join our team as a Senior Product Manager in the Cisnic Oncology sector. Drive innovative disease management campaigns, collaborate with cross-functional teams, and engage with key opinion leaders. Leverage your pharmaceutical marketing expertise and project management skills to make a real impact in advancing healthcare. Shape the future of cancer treatment with Roche.
---
TITLE: Senior Formulation Scientist (Drug Product) - Eurofins CDMO Alphora, Inc.
EMPLOYER: Eurofins Scientific
LOCATION: Mississauga, ON, Canada (unspecified)
SALARY: $90K-$90K
POSTED: 2026-06-10
K401_MATCH: yes (not source-backed)
APPLY_URL: https://jobs.smartrecruiters.com/Eurofins/744000128559187-senior-formulation-scientist-drug-product-eurofins-cdmo-alphora-inc-
EXCERPT: Senior Formulation Scientist (Drug Product) - Eurofins CDMO Alphora, Inc. Mississauga, ON, Canada Company Description: Eurofins Scientific is an international life sciences company, providing a unique range of analytical testing services to clients across multiple industries, to make life and our environment safer, healthier and more sustainable. From the food you eat, to the water you drink, to the medicines you rely on, Eurofins works with the biggest companies in the world to ensure the products they supply are safe, their ingredients are authentic and labelling is accurate. Eurofins believes it is a global leader in food, environmental, pharmaceutical and cosmetics products testing and in agroscience CRO services. It is also one of the global independent market leaders in certain testing and laboratory services for genomics, discovery pharmacology, forensics, CDMO, advanced material sciences and in the support of clinical studies. In over 35 years, Eurofins has grown from one laboratory in Nantes, France to 61,000 staff across a decentralised and entrepreneurial network of ca. 900 laboratories in 61 countries. Eurofins companies offer a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products. In 2025, Eurofins generated total revenues of EUR 7.296 billion, and has been among the best performing stocks in Europe over the past 20 years. Eurofins CDMO Alphora Inc. develops and manufactures new therapeutics to improve the lives and health of patients. Eurofins CDMO Alphora provides contract research & development services to global pharmaceutical and
---
TITLE: Pharmaceutical Manufacturer Relations Executive
EMPLOYER: Humana Inc.
LOCATION: Remote Nationwide (remote)
SALARY: Not disclosed
POSTED: 2026-06-10
K401_MATCH: yes (not source-backed)
APPLY_URL: https://humana.wd5.myworkdayjobs.com/CenterWell_External_Career_Site/job/Remote-Nationwide/Pharmaceutical-Manufacturer-Relations-Executive_R-419074
EXCERPT: Pharmaceutical Manufacturer Relations Executive Remote Nationwide posted: Posted 2 Days Ago
---
TITLE: Senior Manager, Clinical Data Management - External Data Management
EMPLOYER: Crinetics Pharmaceuticals INC
LOCATION: Remote (remote)
SALARY: $138K-$172K
POSTED: 2026-06-07
K401_MATCH: yes (not source-backed)
APPLY_URL: https://crinetics.wd12.myworkdayjobs.com/CrineticsCareers/job/Remote/Senior-Manager--Clinical-Data-Management---External-Data-Management_JR000626
EXCERPT: Senior Manager, Clinical Data Management - External Data Management Remote Crinetics is a pharmaceutical company based in San Diego, California, developing much-needed therapies for people with endocrine diseases and endocrine-related tumors. We were founded by a dedicated team of scientists with the simple belief that better therapies developed from rigorous innovation can lead to better lives. Our work continues to make a real difference in the lives of patients. We have a prolific discovery engine and a robust preclinical and clinical development pipeline. We are driven by science with a patient-centric and team-oriented culture. Crinetics is known for its inclusive workplace culture. We are also a dog-friendly workplace. This is an exciting time to join Crinetics as we shape our organization into the world's premier fully-integrated endocrine company from discovery to patients. Join our team as we transform the lives of others. Position Summary: The Senior Manager, Clinical Data Management - External Data Management (CDM‑EDM) is a hands‑on, individual contributor role responsible for executing and owning external (non‑EDC) data management activities for assigned clinical studies. This position focuses on direct execution and plays a critical role in ensuring external vendor data are timely, high quality, inspection‑ready, and fit for statistical analysis and regulatory submission. The role partners closely with external vendors, CROs, and internal cross‑functional stakeholders to set up data transfer agreements (DTAs), validate test files, manage ongoing data transfers, and perform data reconciliation and quality control activities in compliance with ICH‑GCP, 21 CFR Part 11, and internal SOPs. Essential
---
TITLE: Lead Director, Pharmaceutical Contracting
EMPLOYER: CVS Health Corporation
LOCATION: 4 Locations (unspecified)
SALARY: Not disclosed
POSTED: 2026-06-10
PARENTAL_LEAVE_WEEKS: 4 (not source-backed)
NON_BIRTH_PARENT_LEAVE_WEEKS: 4 (not source-backed)
K401_MATCH: yes (not source-backed)
APPLY_URL: https://cvshealth.wd1.myworkdayjobs.com/CVS_Health_Careers/job/IL---Downers-Grove/Lead-Director--Pharmaceutical-Contracting_R0933942
EXCERPT: Lead Director, Pharmaceutical Contracting 4 Locations posted: Posted 2 Days Ago
---
TITLE: SBM/BM-Pantumor-上海
EMPLOYER: AstraZeneca
LOCATION: China (unspecified)
SALARY: Not disclosed
POSTED: 2026-06-02
K401_MATCH: yes (not source-backed)
APPLY_URL: https://astrazeneca.wd3.myworkdayjobs.com/Careers/job/China/SBM-BM-Pantumor-_R-253543
EXCERPT: SBM/BM-Pantumor-上海 China posted: Posted 10 Days Ago
---
TITLE: Pharmaceutical Internship - Pharmaziepraktikum* (f/m/d)
EMPLOYER: The Procter & Gamble Company
LOCATION: Schwalbach Am Taunus (unspecified)
SALARY: Not disclosed
POSTED: 2026-05-18
PARENTAL_LEAVE_WEEKS: 8 (not source-backed)
NON_BIRTH_PARENT_LEAVE_WEEKS: 8 (not source-backed)
K401_MATCH: yes (not source-backed)
APPLY_URL: https://pg.wd5.myworkdayjobs.com/1000/job/Schwalbach-Am-Taunus/Pharmaceutical-Internship----Pharmaziepraktikum---f-m-d-_R000151566
EXCERPT: Pharmaceutical Internship - Pharmaziepraktikum* (f/m/d) Schwalbach Am Taunus posted: Posted 25 Days Ago
---
TITLE: Pharmaceutical Product Operator - All Shifts
EMPLOYER: Medline Inc.
LOCATION: Waukegan, Illinois (unspecified)
SALARY: Not disclosed
POSTED: 2026-05-14
K401_MATCH: yes (not source-backed)
APPLY_URL: https://medline.wd5.myworkdayjobs.com/Medline/job/Waukegan-Illinois/Pharmaceutical-Product-Operator_R2605410
EXCERPT: Pharmaceutical Product Operator - All Shifts Waukegan, Illinois posted: Posted 29 Days Ago
---
TITLE: Senior Director, Biostatistics, Europe
EMPLOYER: Revolution Medicines
LOCATION: Remote (Switzerland) (remote)
SALARY: Not disclosed
POSTED: 2026-04-10
K401_MATCH: yes (not source-backed)
APPLY_URL: https://www.revmed.com/careers-list/?gh_jid=7694347003
EXCERPT: Senior Director, Biostatistics, Europe Remote (Switzerland) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Playing a critical role as a lead statistician for clinical program(s) and the subject matter expert (SME) in Biostatistics within the Quantitative Sciences function, this position is to provide statistical leadership and support for EU access strategies, healthcare technology assessments and regulatory submissions. - Serve as the statistical lead for European access strategies, ensuring alignment between Global Clinical Development, European regulatory (EMA, MHRA, Swissmedic...) and regional/local Market Access needs to support successful European launches in collaboration with global and regional crossfunctional teams. - Partner with Regional and Local Market Access and HEOR functions to design and lead/oversee the execution of statistical analyses required for value dossiers, including PICO, indirect treatment comparisons, network meta-analyses, and RWE generation. - Partner closely with the development statistical lead, provide statistical support for EU regulatory interactions, including EMA Scientific Advice, MAA, Type II variations, and post-authorization commitments. - Ensure statistical methodologies
---
TITLE: Patient Support Manager - Southeast
EMPLOYER: Biocryst Pharmaceuticals INC
LOCATION: 3 Locations (unspecified)
SALARY: Not disclosed
POSTED: 2026-05-21
K401_MATCH: yes (not source-backed)
APPLY_URL: https://biocryst.wd501.myworkdayjobs.com/External/job/US_North-Carolina_Remote/Patient-Support-Manager---Southeast_JR100141
EXCERPT: Patient Support Manager - Southeast 3 Locations COMPANY: At BioCryst, we share a deep commitment to improving the lives of people living with hereditary angioedema (HAE) and other rare diseases. We leverage our expertise in structure-guided drug design to develop first-in-class or best-in-class oral small-molecule and injectable protein therapeutics, led by the efforts of our team of expert scientists in our Discovery Center of Excellence in Birmingham, Alabama. Our global headquarters is in Durham, North Carolina and our employees span the globe across sites in multiple countries. We are proud of our culture of engagement and accountability that rewards people for innovative thinking and achievement of key objectives. For more information, please visit our website at www.biocryst.com or follow us on LinkedIn and Instagram. ESSENTIAL DUTIES & RESPONSIBILITIES: Direct the access support between consented patients and all relevant stakeholders (Pharmacy, MDO, support organizations). Oversee quality-control efforts relating to Pharmacy interface with payers for consented patients. Direct and coordinate onboarding of all new consented patients. Manage patient status changes within Patient Services CRM and follow-up with internal stakeholders and pharmacy. Enforce Patient Support Program business rules to administer access to these programs. Manage and communicate reimbursement-related information to consented patients and MDOs Control the flow of information to and communication touch-points with consented patients. Support adherence efforts. Collaborate with Market Access to execute regional reimbursement patient educational events. Create and manage a comprehensive product access and patient support plan for consented patients. Lead the cross-functional execution activities. Lead weekly meetings with
---
TITLE: Apprentice Chemical and Pharmaceutical Technologist 2026
EMPLOYER: Biogen
LOCATION: Solothurn, Switzerland (unspecified)
SALARY: Not disclosed
POSTED: 2026-05-12
K401_MATCH: yes (not source-backed)
APPLY_URL: https://biibhr.wd3.myworkdayjobs.com/external/job/Solothurn-Switzerland/Apprentice-Chemical-and-Pharmaceutical-Technologist-2026_REQ21851
EXCERPT: Apprentice Chemical and Pharmaceutical Technologist 2026 Solothurn, Switzerland posted: Posted 30+ Days Ago
---
TITLE: Senior Manager, Marketing, Lung
EMPLOYER: Revolution Medicines
LOCATION: Remote (United States) (remote)
SALARY: $150K-$189K
POSTED: 2026-06-09
K401_MATCH: yes (not source-backed)
APPLY_URL: https://www.revmed.com/careers-list/?gh_jid=7767420003
EXCERPT: Senior Manager, Marketing, Lung Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: As a Senior Marketing Manager, you will be a key contributor to the development of compelling omnichannel campaigns that promote Revolution Medicine's values, scientific innovation, and patient centricity. You will develop and execute marketing strategies and plans to achieve brand objectives and growth targets, particularly for non-personal promotion initiatives. Identification and implementation of innovative digital promotion technologies will be essential to this role. You will also collaborate cross-functionally and support media planning, campaign measurement, campaign asset promotional review, and related expense budgets. - Engages in strategic market planning through developing and executing marketing strategies for lung cancer products and indications. - Understands customer needs and preferences to create engaging and effective marketing campaigns. - Oversees the execution of marketing campaigns across various channels, including digital, print, and field-based resources. - Tracks and analyzes marketing campaign performance to identify areas for improvement and provide recommendations for
---
TITLE: Pharmaceutical Production Technician - All Shifts
EMPLOYER: Medline Inc.
LOCATION: Waukegan, Illinois (unspecified)
SALARY: Not disclosed
POSTED: 2026-05-14
K401_MATCH: yes (not source-backed)
APPLY_URL: https://medline.wd5.myworkdayjobs.com/Medline/job/Waukegan-Illinois/Pharmaceutical-Production-Technician---All-Shifts_R2605411
EXCERPT: Pharmaceutical Production Technician - All Shifts Waukegan, Illinois posted: Posted 29 Days Ago
---
TITLE: ERP Systems Senior Manager (NetSuite)
EMPLOYER: Revolution Medicines
LOCATION: Redwood City, California, United States (unspecified)
SALARY: $164K-$205K
POSTED: 2026-04-10
K401_MATCH: yes (not source-backed)
APPLY_URL: https://www.revmed.com/careers-list/?gh_jid=7695632003
EXCERPT: ERP Systems Senior Manager (NetSuite) Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking a ERP Systems Senior Manager to serve as the primary owner and hands-on lead for NetSuite OneWorld, supporting our growing global operations and commercialization readiness. This is an individual contributor role responsible for both day-to-day system execution and longer-term ERP design and scalability. You will partner closely with Finance, FP&A, Accounting, Tax, Procurement, and IT to ensure NetSuite is accurate, compliant, scalable, and tightly aligned with business processes. This role combines deep hands-on system configuration and support with the ability to design and continuously improve ERP capabilities as the organization grows. You will play a critical role in maintaining financial integrity, supporting global entity expansion, optimizing inventory and product costing, and ensuring seamless integration across enterprise systems including Workday, Coupa, Concur, ADP, and middleware platforms. This role is pivotal in building sustainable, audit-ready ERP operations to support scale and
---
TITLE: Pharmaceutical Representative (Dnipro)
EMPLOYER: Abbott Laboratories
LOCATION: Ukraine > Kyiv: Senator Business Center (unspecified)
SALARY: Not disclosed
POSTED: 2026-06-11
PARENTAL_LEAVE_WEEKS: 8 (not source-backed)
NON_BIRTH_PARENT_LEAVE_WEEKS: 8 (not source-backed)
K401_MATCH: yes (not source-backed)
APPLY_URL: https://abbott.wd5.myworkdayjobs.com/abbottcareers/job/Ukraine--Kyiv-Senator-Business-Center/Pharmaceutical-Representative--Dnipro-_31153247
EXCERPT: Pharmaceutical Representative (Dnipro) Ukraine > Kyiv: Senator Business Center posted: Posted Yesterday
---
TITLE: Sr. Advanced Analytics Manager
EMPLOYER: Biocryst Pharmaceuticals INC
LOCATION: US_North Carolina_Remote (unspecified)
SALARY: Not disclosed
POSTED: 2026-05-23
K401_MATCH: yes (not source-backed)
APPLY_URL: https://biocryst.wd501.myworkdayjobs.com/External/job/US_North-Carolina_Remote/Sr-Advanced-Analytics-Manager_JR100112
EXCERPT: Sr. Advanced Analytics Manager US_North Carolina_Remote COMPANY: At BioCryst, we share a deep commitment to improving the lives of people living with hereditary angioedema (HAE) and other rare diseases. We leverage our expertise in structure-guided drug design to develop first-in-class or best-in-class oral small-molecule and injectable protein therapeutics, led by the efforts of our team of expert scientists in our Discovery Center of Excellence in Birmingham, Alabama. Our global headquarters is in Durham, North Carolina and our employees span the globe across sites in multiple countries. We are proud of our culture of engagement and accountability that rewards people for innovative thinking and achievement of key objectives. For more information, please visit our website at www.biocryst.com or follow us on LinkedIn and Instagram. JOB SUMMARY: The Sr. Advanced Analytics Manager will be responsible for managing analytics activities to support a data-driven culture within BioCryst by developing and applying analytic methodologies to deepen insights and inform commercial business decisions. The Sr. Advanced Analytics Manager will be a key member of teams responsible for the support of BioCryst's first commercial product launch of ORLADEYO for the treatment of hereditary angioedema, in addition to other products in the BioCryst rare disease pipeline. ESSENTIAL DUTIES & RESPONSIBILITIES: Advanced Analytics Partner with Advanced Analytics, Market Insights and Strategic Operations to integrate data, analytical methods, and insights across the organization to help inform strategic choices and measure performance. Lead the implementation and execution of commercial sales incentive plans to drive sales performance and to ensure alignment
---
TITLE: Demand Planner
EMPLOYER: Novartis
LOCATION: Bogota (Pharmaceuticals / GDD / NTO / CTS) (unspecified)
SALARY: Not disclosed
POSTED: 2026-05-18
K401_MATCH: yes (not source-backed)
APPLY_URL: https://novartis.wd3.myworkdayjobs.com/Internal_Careers_for_Acquired_Entities/job/Bogota-Pharmaceuticals--GDD--NTO--CTS/Demand-Planner_REQ-10078093
EXCERPT: Demand Planner Bogota (Pharmaceuticals / GDD / NTO / CTS) posted: Posted 25 Days Ago
---
TITLE: Director, Alliance Management
EMPLOYER: Revolution Medicines
LOCATION: Redwood City, California, United States (unspecified)
SALARY: $211K-$264K
POSTED: 2026-02-18
K401_MATCH: yes (not source-backed)
APPLY_URL: https://www.revmed.com/careers-list/?gh_jid=7613271003
EXCERPT: Director, Alliance Management Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the Revolution Medicines team, you will join other outstanding Revolutionaries in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Director, Alliance Management will serve as a key liaison between RevMed and its strategic partners, ensuring the success of collaborations across research and development. This role requires a dynamic leader with strong relationship management skills and the ability to drive alignment between internal teams and external stakeholders to achieve shared objectives. - Strategic Partnership Management: Oversee a variety of strategic alliances with industry and academic partners
---
TITLE: Commercial Excellence Manager (Pharmaceutical / Lifesciences)
EMPLOYER: IQVIA
LOCATION: Leiden, Netherlands (unspecified)
SALARY: Not disclosed
POSTED: 2026-06-04
K401_MATCH: yes (not source-backed)
APPLY_URL: https://iqvia.wd1.myworkdayjobs.com/IQVIA/job/Leiden-Netherlands/Commercial-Excellence-Manager--Pharmaceutical---Lifesciences-_R1549255
EXCERPT: Commercial Excellence Manager (Pharmaceutical / Lifesciences) Leiden, Netherlands posted: Posted 8 Days Ago
---
TITLE: Chemielaborant/Pharmakant/Chemikant/PTA/CTA/BTA für die Herstellung parenteraler klinischer Prüfpräparate (all genders) (Vollzeit, unbefristet)
EMPLOYER: AbbVie Inc.
LOCATION: Ludwigshafen, RP, Germany (unspecified)
SALARY: Not disclosed
POSTED: 2026-06-10
PARENTAL_LEAVE_WEEKS: 12 (not source-backed)
NON_BIRTH_PARENT_LEAVE_WEEKS: 12 (not source-backed)
K401_MATCH: yes (not source-backed)
APPLY_URL: https://jobs.smartrecruiters.com/AbbVie/3743990012977056-chemielaborant-pharmakant-chemikant-pta-cta-bta-fur-die-herstellung-parenteraler-klinischer-prufpraparate-all-genders-vollzeit-unbefristet-
EXCERPT: Chemielaborant/Pharmakant/Chemikant/PTA/CTA/BTA für die Herstellung parenteraler klinischer Prüfpräparate (all genders) (Vollzeit, unbefristet) Ludwigshafen, RP, Germany Unternehmensbeschreibung: About AbbVie AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology and neuroscience - and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com . Follow @abbvie on LinkedIn, Facebook , Instagram , X and YouTube. Stellenbeschreibung: Herzlich willkommen bei Abbvie! Als Teil eines internationalen Unternehmens mit über 48.000 Mitarbeitern weltweit und rund 3.000 Mitarbeitern in Deutschland hast Du die Möglichkeit, eng mit uns zusammenzuarbeiten, um die gesundheitlichen Herausforderungen von morgen zu meistern. Du hast eine Leidenschaft für die Verbesserung der Gesundheitsversorgung auf der ganzen Welt? Du möchtest Dein Fachwissen einsetzen, um die Lebensqualität von Patienten zu verbessern? In einem herausfordernden Arbeitsumfeld, das Dir die Möglichkeit bietet, Deine eigenen Fähigkeiten zu erweitern und zu entwickeln? Dann bist Du bei uns richtig! Gemeinsam großes bewegen - als Chemielaborant/Pharmakant/Chemikant/PTA/CTA/BTA für die Herstellung parenteraler klinischer Prüfpräparate (all genders) Für unser motiviertes und engagiertes Team in der Entwicklung und Herstellung von parenteralen Arzneiformen suchen wir tatkräftige Unterstützung. Routine ist uns fremd, da unsere Abteilung an innovativen Prozessen und Produkten für klinische Studien arbeitet und einen reibungslosen Transfer aus der Entwicklung in die Herstellung klinischer Prüfpräparate gewährleistet. Unsere Aufgaben und Chargengrößen passen sich den jeweiligen Forschungs- und Entwicklungsprojekten
---
TITLE: Manager, Pharmaceutical Sales Training
EMPLOYER: Asahi Kasei Corp.
LOCATION: Cary, NC (unspecified)
SALARY: Not disclosed
POSTED: 2026-05-12
K401_MATCH: yes (not source-backed)
APPLY_URL: https://akamerica.wd501.myworkdayjobs.com/aka/job/Cary-NC/Manager--Pharmaceutical-Sales-Training_R5468-1
EXCERPT: Manager, Pharmaceutical Sales Training Cary, NC posted: Posted 30+ Days Ago
---
TITLE: Senior Director, Executive & Enterprise Communications
EMPLOYER: Revolution Medicines
LOCATION: Redwood City, California, United States (unspecified)
SALARY: $244K-$305K
POSTED: 2026-05-01
K401_MATCH: yes (not source-backed)
APPLY_URL: https://www.revmed.com/careers-list/?gh_jid=7613269003
EXCERPT: Senior Director, Executive & Enterprise Communications Redwood City, California, United States Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Senior Director, Executive & Enterprise Communications will serve as a trusted communications advisor to the CEO and select senior leaders while leading enterprise internal communications across a growing global organization. This is a high-impact role for a communicator who can operate strategically and execute with excellence. Success in this position requires sound judgment, executive presence, strong writing skills, and the ability to move seamlessly between shaping a CEO keynote and building the communications infrastructure that keeps teams informed, aligned, and engaged. Reporting to the Head of Communications, this role partners closely with the Corporate Communications lead, the Associate Director of Internal Communications, and regional communications and HR partners globally. This is a rare opportunity to work directly with RevMed's executive leadership team, shaping executive voice, internal culture, and enterprise communications at a company rapidly building toward commercial stage. Key responsibilities
---
TITLE: Pharmaceutical QC Technical Services Manager
EMPLOYER: Smithfield Foods
LOCATION: Cincinnati, OH (unspecified)
SALARY: Not disclosed
POSTED: 2026-05-22
K401_MATCH: yes (not source-backed)
APPLY_URL: https://smithfieldfoods.wd1.myworkdayjobs.com/Careers/job/Cincinnati-OH/Pharmaceutical-QC-Technical-Services-Manager_R-2026-6094
EXCERPT: Pharmaceutical QC Technical Services Manager Cincinnati, OH posted: Posted 21 Days Ago
---
TITLE: Field Reimbursement Manager (FRM), Endocrinology - Atlanta/Carolinas
EMPLOYER: Corcept Therapeutics
LOCATION: Atlanta, Georgia, United States (unspecified)
SALARY: $154K-$200K
POSTED: 2026-05-29
K401_MATCH: yes (not source-backed)
APPLY_URL: https://www.corcept.com/careers/current-opportunities/?gh_jid=6009586004
EXCERPT: Field Reimbursement Manager (FRM), Endocrinology - Atlanta/Carolinas Atlanta, Georgia, United States For more than 25 years, Corcept has been singularly focused on the science of cortisol, a powerful hormone that when unregulated, can play a role in a broad range of diseases. Our commercial portfolio includes treatments for hypercortisolism and oncology, and the company has discovered more than 1,000 proprietary selective cortisol modulators and glucocorticoid receptor antagonists. With advanced clinical trials in patients with hypercortisolism, solid tumors, ALS and liver disease, Corcept is unlocking the power of cortisol modulation to help address some of the most devastating diseases patients face today. Corcept is headquartered in Redwood City, California. To learn more, visit www.corcept.com . The Field Reimbursement Manager (FRM), Endocrinology plays a critical role in ensuring that patients who need our therapies can access them, efficiently, reliably, and with the support they deserve. This role serves as the subject matter expert on access and reimbursement for Korlym, Mifepristone AG, and Relacorilant, supporting healthcare providers (HCPs), field sales teams, specialty pharmacies (SPs), and our patient support HUB to resolve barriers to patient access. The FRM will deliver education, troubleshoot complex reimbursement challenges, and work collaboratively across functions to ensure successful initiation and continuation of therapy for appropriate patients. FRMs are natural problem-solvers and relationship-builders who thrives in a dynamic, patient-centric environment. They bring deep knowledge of the access landscape and excel at navigating payer policies, benefits verifications, prior authorizations, and reimbursement and access logistics. Responsibilities: Support Patient Access & Pull-Through -
---
TITLE: Pharmaceutical Information Specialist
EMPLOYER: Merck & Co., Inc.
LOCATION: CHN - Shanghai - Shanghai (Tower A) (unspecified)
SALARY: Not disclosed
POSTED: 2026-06-05
K401_MATCH: yes (not source-backed)
APPLY_URL: https://msd.wd5.myworkdayjobs.com/SearchJobs/job/CHN---Shanghai---Shanghai-Tower-A/Pharmaceutical-Information-Specialist_R401276-1
EXCERPT: Pharmaceutical Information Specialist CHN - Shanghai - Shanghai (Tower A) posted: Posted 7 Days Ago
---
TITLE: Manager, Market Intelligence and Strategy
EMPLOYER: Entrada Therapeutics Inc
LOCATION: Boston, MA (unspecified)
SALARY: $127K-$166K
POSTED: 2026-05-08
PARENTAL_LEAVE_WEEKS: 0 (not source-backed)
K401_MATCH: yes (not source-backed)
LEARNING_BUDGET_OFFERED: yes (not source-backed)
APPLY_URL: https://job-boards.greenhouse.io/entradatherapeutics/jobs/5132958007
EXCERPT: Manager, Market Intelligence and Strategy Boston, MA The Organization What's happening at Entrada Therapeutics? Entrada is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. Through proprietary and versatile approaches, Entrada is advancing a robust development portfolio of genetic medicines for the potential treatment of neuromuscular and inherited retinal diseases, among others. Our lead oligonucleotide programs are in development for the potential treatment of people living with Duchenne muscular dystrophy (DMD) who are exon 44, 45, 50 and 51 skipping amenable. Entrada has partnered with Vertex Pharmaceuticals to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1 (DM1). 2026 represents a catalyst-rich period for Entrada. We expect multiple clinical data readouts as we advance several DMD programs across the U.K., EU, and U.S. By year-end 2026, we anticipate four clinical-stage programs in our DMD franchise (ENTR-601-44, ENTR-601-45, ENTR-601-50, and ENTR-601-51). These programs are complemented by the ongoing clinical progress of our DM1 collaboration with Vertex (VX-670). We are a tight-knit team of experts and leaders in both therapeutic development and rare diseases and are excited to grow and attract colleagues who are ready to join a high-energy, dedicated team that likes to get things done and dramatically improve the lives of patients and their families. The Perfect Addition to Our Team You are interested in working at the intersection of life sciences and business. You want to join a high
---
TITLE: Pharmaceutical Operator
EMPLOYER: Ashland Global
LOCATION: US-OH-COLUMBUS (ATLAS) (unspecified)
SALARY: Not disclosed
POSTED: 2026-05-27
APPLY_URL: https://ashland.wd12.myworkdayjobs.com/AshlandCareers1/job/US-OH-COLUMBUS-ATLAS/Pharmaceutical-Operator_2026-0250
EXCERPT: Pharmaceutical Operator US-OH-COLUMBUS (ATLAS) posted: Posted 16 Days Ago
---
TITLE: Senior Manager, Sales Operations & Analytics
EMPLOYER: Revolution Medicines
LOCATION: Remote (United States) (remote)
SALARY: $150K-$189K
POSTED: 2026-04-10
K401_MATCH: yes (not source-backed)
APPLY_URL: https://www.revmed.com/careers-list/?gh_jid=7697166003
EXCERPT: Senior Manager, Sales Operations & Analytics Remote (United States) Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Senior Manager, Sales Operations & Analytics, reporting to the Senior Director, Sales Operations & Analytics, plays a key role in enabling US Commercial field teams to execute with clarity and impact. This leader partners cross-functionally to translate strategy into scalable processes, actionable insights, and effective, pragmatic, high-impact tools that drive alignment and position the field for success. This individual will support seamless, coordinated commercial field enablement through: Field Operations & Governance - Translate commercial strategy into clear, compliant, and executable field processes. - Lead operating cadence, governance forums, and communications to drive alignment and accountability. - Maintain SOPs and field standards to ensure consistent execution. Sales Systems, Territory & Data - Oversee operations and infrastructure of core field enablement systems including CRM, alignment management, roster management, and sales crediting. - Ensure data integrity, system adoption, territory accuracy, and reporting reliability. - Lead
---
TITLE: Pharmaceutical Information Manager
EMPLOYER: Merck & Co., Inc.
LOCATION: CHN - Shanghai - Shanghai (Trading) (unspecified)
SALARY: Not disclosed
POSTED: 2026-06-04
K401_MATCH: yes (not source-backed)
APPLY_URL: https://msd.wd5.myworkdayjobs.com/SearchJobs/job/CHN---Shanghai---Shanghai-Trading/Pharmaceutical-Information-Manager_R401755-2
EXCERPT: Pharmaceutical Information Manager CHN - Shanghai - Shanghai (Trading) posted: Posted 8 Days Ago
---
TITLE: Medical Science Liaison, Immunology (Derma)
EMPLOYER: AbbVie Inc.
LOCATION: Remote | Sofia, Sofia City Province, Bulgaria (remote)
SALARY: Not disclosed
POSTED: 2026-06-10
PARENTAL_LEAVE_WEEKS: 12 (not source-backed)
NON_BIRTH_PARENT_LEAVE_WEEKS: 12 (not source-backed)
K401_MATCH: yes (not source-backed)
APPLY_URL: https://jobs.smartrecruiters.com/AbbVie/3743990012888796-medical-science-liaison-immunology-derma-
EXCERPT: Medical Science Liaison, Immunology (Derma) Remote | Sofia, Sofia City Province, Bulgaria Company Description: About AbbVie AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology and neuroscience - and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com . Follow @abbvie on LinkedIn, Facebook , Instagram , X and YouTube. Job Description: Represent AbbVie Medical Affairs as subject matter expert in the assigned TA and territory, provide scientific and technical leadership to ensure professional and credible relationships with external experts /HCPs of strategic importance to AbbVie. Serve as a point of contact within the Medical Affairs team for external experts within an assigned geographic area in order to satisfy their needs for scientific knowledge in a therapeutic area and, when requested, relevant AbbVie medicines, to support their safe, effective and appropriate use. Develop and execute scientific interaction plans, cycle plans; contribute to cross-functional account planning, as appropriate. Responsible for appropriate tiering and segmentation of external experts based on guidance from the IFT playbooks and appropriate documentation of HCP interactions and relevant insights in the CRS and related platforms and systems. Ensure a strong medical and scientific presence for AbbVie in key academic centers by facilitation of research and educational initiatives, while supporting requests for medical and scientific information
---
TITLE: Pharmaceutical Sales Representative- Glendale,CA
EMPLOYER: GSK plc
LOCATION: 4 Locations (unspecified)
SALARY: Not disclosed
POSTED: 2026-06-02
K401_MATCH: yes (not source-backed)
APPLY_URL: https://gsk.wd5.myworkdayjobs.com/GSKCareers/job/USA---California---Los-Angeles/Pharmaceutical-Sales-Representative--Glendale-CA_441304
EXCERPT: Pharmaceutical Sales Representative- Glendale,CA 4 Locations posted: Posted 10 Days Ago
---
TITLE: Vice President, Pharmaceutical Development
EMPLOYER: Kymera Therapeutics Inc
LOCATION: Watertown, MA (unspecified)
SALARY: $315K-$395K
POSTED: 2026-05-26
K401_MATCH: yes (not source-backed)
APPLY_URL: https://www.kymeratx.com/careers-culture/working-at-kymera/?gh_jid=7748334003#open-positions
EXCERPT: Vice President, Pharmaceutical Development Watertown, MA Who we are: Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients' lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on building an industry-leading pipeline of oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Founded in 2016, Kymera has been recognized as one of Boston's top workplaces for the past several years. For more information about our science, pipeline and people, please visit www.kymeratx.com or follow us on X (formerly Twitter) or LinkedIn . How we work: - PIONEER : We are courageous, resilient and rigorous in our mission to improve patients' lives through our revolutionary degrader medicines. - COLLABORATE : We value trust + transparency from everyone. Our goals are shared, our decisions data-driven and our camaraderie genuine. - BELONG : We recognize our differences, inviting curiosity and inclusivity, so that our people are valued, seen, and heard. How you'll make an impact: - Define and lead the company's pharmaceutical development strategy across the portfolio, ensuring alignment with corporate priorities and development timelines - Provide strategic leadership for preformulation, biopharmaceutics, and formulation development activities supporting discovery, preclinical, and clinical-stage programs - Champion innovation in formulation sciences and enabling technologies to
---
TITLE: Pharmaceutical Laboratory Analyst
EMPLOYER: Ashland Global
LOCATION: US-OH-COLUMBUS (ATLAS) (unspecified)
SALARY: Not disclosed
POSTED: 2026-05-20
APPLY_URL: https://ashland.wd12.myworkdayjobs.com/AshlandCareers1/job/US-OH-COLUMBUS-ATLAS/Pharmaceutical-Laboratory-Analyst_2026-0235
EXCERPT: Pharmaceutical Laboratory Analyst US-OH-COLUMBUS (ATLAS) posted: Posted 23 Days Ago
---
TITLE: Manager, Sales Force & Channel Effectiveness - Oncology- 12 month contrac
EMPLOYER: AstraZeneca
LOCATION: Canada - Mississauga (unspecified)
SALARY: Not disclosed
POSTED: 2026-06-09
K401_MATCH: yes (not source-backed)
APPLY_URL: https://astrazeneca.wd3.myworkdayjobs.com/Careers/job/Canada---Mississauga/Manager--Sales-Force---Channel-Effectiveness---Oncology--12-month-contrac_R-252945
EXCERPT: Manager, Sales Force & Channel Effectiveness - Oncology- 12 month contrac Canada - Mississauga posted: Posted 3 Days Ago
---
TITLE: Business Development Associate - Pharmaceutical
EMPLOYER: Ecolab
LOCATION: USA - North Carolina - Raleigh (unspecified)
SALARY: Not disclosed
POSTED: 2026-05-12
PARENTAL_LEAVE_WEEKS: 6 (not source-backed)
NON_BIRTH_PARENT_LEAVE_WEEKS: 6 (not source-backed)
K401_MATCH: yes (not source-backed)
APPLY_URL: https://ecolab.wd1.myworkdayjobs.com/Ecolab_External/job/USA---North-Carolina---Raleigh/Business-Development-Associate---Pharmaceutical_R00293604
EXCERPT: Business Development Associate - Pharmaceutical USA - North Carolina - Raleigh posted: Posted 30+ Days Ago
---
TITLE: Pharmaceutical Sales Representative - Raleigh-Durham NC
EMPLOYER: IQVIA
LOCATION: 2 Locations (unspecified)
SALARY: Not disclosed
POSTED: 2026-06-11
K401_MATCH: yes (not source-backed)
APPLY_URL: https://iqvia.wd1.myworkdayjobs.com/IQVIA/job/Raleigh-NC/Pharmaceutical-Sales-Representative---Raleigh-Durham-NC_R1550762
EXCERPT: Pharmaceutical Sales Representative - Raleigh-Durham NC 2 Locations posted: Posted Yesterday
---
TITLE: 高级治疗领域专员 - 肺癌治疗领域 - 唐山
EMPLOYER: Roche Holding AG
LOCATION: Tangshan, Hebei, China's Mainland (unspecified)
SALARY: Not disclosed
POSTED: 2026-05-14
APPLY_URL: https://roche.wd3.myworkdayjobs.com/roche-ext/job/Tangshan/------_202605-111973-1/apply
EXCERPT: 高级治疗领域专员 - 肺癌治疗领域 - 唐山 Tangshan, Hebei, China's Mainland Join our team as a Senior Treatment Specialist in Cancerology, where you'll drive scientific communication, support clinical teams, and help shape treatment standards. Leverage your expertise to improve patient outcomes and collaborate across disciplines in a dynamic, innovative environment. Grow your career with a global leader in healthcare solutions.
---
TITLE: Pharmaceutical Sales Representative - Washington DC
EMPLOYER: IQVIA
LOCATION: Washington DC, DC (unspecified)
SALARY: Not disclosed
POSTED: 2026-05-28
K401_MATCH: yes (not source-backed)
APPLY_URL: https://iqvia.wd1.myworkdayjobs.com/IQVIA/job/Washington-DC-DC/Pharmaceutical-Sales-Representative---Washington-DC_R1547672
EXCERPT: Pharmaceutical Sales Representative - Washington DC Washington DC, DC posted: Posted 15 Days Ago
---
TITLE: Senior Director, Medical Affairs, Midsized Markets Europe
EMPLOYER: Revolution Medicines
LOCATION: Basel, Basel-Stadt, Switzerland (unspecified)
SALARY: Not disclosed
POSTED: 2026-05-05
K401_MATCH: yes (not source-backed)
APPLY_URL: https://www.revmed.com/careers-list/?gh_jid=7725127003
EXCERPT: Senior Director, Medical Affairs, Midsized Markets Europe Basel, Basel-Stadt, Switzerland Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: Reporting to the VP, GM, Midsized Markets, the Senior Director, Medical Affairs, Midsize Markets Europe, is the medical leader responsible for defining and executing the medical strategy for oncology products in our portfolio within Midsized markets. This role serves as the medical voice within the Midsized markets Leadership Team, ensuring scientific excellence, compliant medical engagement, and strong alignment between global strategy and local patient, physician, and healthcare system needs. This leader will ensure that Midsized markets medical considerations are embedded in the regional medical strategy and plans and will partner with the Midsized markets country managers and crossfunctional teams, as well as VP Head of Europe Medical Affairs and their leadership team. The incumbent will contribute to building the Midsized markets medical team and working closely with the Global, Regional, Country Medical Affairs teams across Med Affairs functions. Responsibilities: - Act as
---
TITLE: Senior Legal Counsel - Pharmaceutical Contracting
EMPLOYER: CVS Health Corporation
LOCATION: RI - Woonsocket (unspecified)
SALARY: Not disclosed
POSTED: 2026-05-26
PARENTAL_LEAVE_WEEKS: 4 (not source-backed)
NON_BIRTH_PARENT_LEAVE_WEEKS: 4 (not source-backed)
K401_MATCH: yes (not source-backed)
APPLY_URL: https://cvshealth.wd1.myworkdayjobs.com/CVS_Health_Careers/job/RI---Woonsocket/Senior-Legal-Counsel---Pharmaceutical-Contracting_R0901888
EXCERPT: Senior Legal Counsel - Pharmaceutical Contracting RI - Woonsocket posted: Posted 17 Days Ago
---

[PASTE YOUR RESUME OR SKILLS HERE]